LMMY logo

Exousia Bio, Inc. Stock Price

OTCPK:LMMY Community·US$8.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

LMMY Share Price Performance

US$0.16
-0.10 (-38.49%)
US$0.16
-0.10 (-38.49%)
Price US$0.16

LMMY Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with slight risk.

4 Risks
0 Rewards

Exousia Bio, Inc. Key Details

US$0

Revenue

US$69.4k

Cost of Revenue

-US$69.4k

Gross Profit

US$10.8k

Other Expenses

-US$80.2k

Earnings

Last Reported Earnings
Nov 30, 2025
Next Reporting Earnings
n/a
-0.0015
0%
0%
0%
View Full Analysis

About LMMY

Founded
2022
Employees
2
CEO
Matthew Dwyer
WebsiteView website
exousiabio.com

Exousia Bio, Inc., a biotechnology company, designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company’s platform enables the custom production of exosomes with enhanced genetic functionality that can selectively target specific cells to address diseases. The company was formerly known as LAMY and changed its name to Exousia Bio, Inc. in January 2026. The company was incorporated in 2022 and is based in Saint Petersburg, Florida.

Recent LMMY News & Updates

Recent updates

No updates